
Series B · New York
Healthtech · Femtech · B2C
Women's hormonal and metabolic health care
Women with PCOS and other hormonal imbalances are Allara's core patients, and its care also covers metabolic problems such as insulin resistance, reproductive health and life stages including perimenopause. More than 60,000 women across the US use the service. Each patient is matched with a multidisciplinary care team, and treatment continues over time with the aim of measurably better health. The company sets out to close gaps in women's healthcare that have long been overlooked.
allarahealth.com (opens in a new tab)$30MVenture RoundOct 2026
Led by Index Ventures; GV
Recent raisesNo open roles right now
Allara has nothing open on the board today. We've tracked 4 roles here so far, and new ones show up here on their own.
Explore all roles